EXPRESSION OF THYROTROPIN RECEPTOR (TSH-R), THYROGLOBULIN, THYROPEROXIDASE, AND CALCITONIN MESSENGER RIBONUCLEIC-ACIDS IN THYROID CARCINOMAS - EVIDENCE OF TSH-R GENE TRANSCRIPT IN MEDULLARY HISTOTYPE
R. Elisei et al., EXPRESSION OF THYROTROPIN RECEPTOR (TSH-R), THYROGLOBULIN, THYROPEROXIDASE, AND CALCITONIN MESSENGER RIBONUCLEIC-ACIDS IN THYROID CARCINOMAS - EVIDENCE OF TSH-R GENE TRANSCRIPT IN MEDULLARY HISTOTYPE, The Journal of clinical endocrinology and metabolism, 78(4), 1994, pp. 867-871
We studied the expression of the TSH receptor (TSH-R), thyroglobulin (
Tg), thyroperoxidase (TPO), and calcitonin (CT) genes in a total of 53
tissues from 30 patients with thyroid carcinoma and from 9 patients w
ith benign thyroid diseases. By Northern blot analysis of total RNA pr
eparations, CT mRNA was expressed in all cases (n = 6) of medullary th
yroid carcinoma (MTC). Surprisingly, 3 of them expressed the TSH-R mRN
A, in association with the Tg and TPO mRNAs in 1. The presence of the
TSH-R transcript in the neoplastic C-cells was confirmed in 1 MTC by i
n situ hybridization using a mixture of 3 oligonucleotide probes deriv
ed from dog TSH-R cDNA. With various degrees of expression, all differ
entiated thyroid carcinomas (20 papillary and 2 follicular) expressed
TSH-R, Tg, and TPO, but not CT mRNAs. On the contrary, samples from 2
patients with anaplastic carcinoma did not express TSH-R, Tg, or TPO m
RNA, but 1 of them expressed CT mRNA. All of the transcripts obtained
from thyroid carcinomas (both primary and metastatic) were of the same
size as the transcripts from normal or benign thyroid tissues, with t
he exception of 2 cases of differentiated thyroid cancer, in which TSH
-R mRNA of lower mol wt (similar to 4.0 kilobases) was found in the ab
sence of alteration in cDNA size and restriction map. The main conclus
ions of our study are that 1) the TSH-R gene is expressed in some MTC,
which supports, at molecular level, the hypothesis of the existence o
f mixed follicular-medullary thyroid tumors; and 2) the expression of
TSH-R, Tg, and TPO in undifferentiated thyroid cancer is lost.